Capturing reuse in altmetrics

Altmetrics are aimed at capturing the amount of attention a paper gets. The adoption has been significantly encouraged by services provided by, for example, Altmetric.com, ImpactStory, and PlumX, which serve the same role as Google Scholar for traditional metrics. The traditional metrics cover f...

By Egon Willighagen

Dissecting the OA Citation Advantage: Bayesian approaches will be superior to randomised control trials

The idea that open access articles are more highly cited is attractive, particularly for open access advocates. While there have been many retrospective cohort analyses that suggest citations advantages of various sizes, randomized control trials have shown no effect. The problem with randomised...

By Cameron Neylon

From Publication to Impact: When publication isn’t enough for patients, measure what matters.

The ultimate beneficiary of a biomedical journal article should be the patient. To realize this benefit, a publication must provide both the rational evidence plus a reason to act on the part of a healthcare professional. Sponsors of clinical trials support a huge volume of peer-reviewed publica...

By Matt Lewis